e-learning
resources
Virtual 2020
Pre-Congress Content
Epidemiology, diagnosis and management of pulmonary embolism
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Identification of patients with intermediate-high-risk PE with poor evolution
M. Acosta Davila (Valencia, Spain), S. Calvache Castillo (Valencia, Spain), C. De Juana Izquierdo (Valencia, Spain), A. Herrejón Silvestre (Valencia, Spain), I. Furest Carrasco (Valencia, Spain)
Source:
Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism
Session:
Epidemiology, diagnosis and management of pulmonary embolism
Session type:
E-poster session
Number:
3580
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Acosta Davila (Valencia, Spain), S. Calvache Castillo (Valencia, Spain), C. De Juana Izquierdo (Valencia, Spain), A. Herrejón Silvestre (Valencia, Spain), I. Furest Carrasco (Valencia, Spain). Identification of patients with intermediate-high-risk PE with poor evolution. 3580
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Comparison of acute phase reactant pentraksin-3 and inflammatory parameters in acute and stable pulmonary embolism
Features of patients newly diagnosed pulmonary embolism during COVID pneumonia
Diagnosis and treatment of chronic pulmonary embolism
Related content which might interest you:
Cluster phenotyping as an approach to identify COPD patients at risk of poor prognosis.
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Identification of p-stage I NSCLC patients with high risk of recurrence and poor prognosis by tumor marker index (TMI)
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011
Predictors of mortality in a well-characterised group of patients with COPD
Source: Annual Congress 2012 - COPD: epidemiology and varia
Year: 2012
Identification of clinical phenotypes using cluster analyses in COPD patients
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
Identification of intermediate-risk patients with acute symptomatic pulmonary embolism
Source: Eur Respir J 2014; 44: 694-703
Year: 2014
Improved identification of thrombolysis candidates amongst intermediate-risk pulmonary embolism patients: implications for future trials
Source: Eur Respir J, 51 (1) 1701775; 10.1183/13993003.01775-2017
Year: 2018
Cluster analysis identifying patients with COPD at high-risk of 2-year mortality: preliminary results.
Source: International Congress 2017 – Assessing the functional status of patients with COPD
Year: 2017
Treatment outcome and risk factors of death in elderly patients diagnosed as new cases of tuberculosis
Source: Annual Congress 2010 - Prognosis of tuberculosis
Year: 2010
Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis?
Source: Eur Respir J 2016; 48: 279-281
Year: 2016
Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis?
Source: Eur Respir J 2016; 48: 281-282
Year: 2016
Combination of prognostic tools for identifying high-risk normotensive patients with acute symptomatic pulmonary embolism
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010
Predicting adverse events from pulmonary embolism (PE): does the wicki score identify patients suitable for early discharge?
Source: Eur Respir J 2003; 22: Suppl. 45, 218s
Year: 2003
Identifying risk groups for any cause hospitalizations in COPD patients
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017
Identifying patients with severe asthma that will be benefit from biological therapy
Source: Virtual Congress 2020 – Rethinking asthma
Year: 2020
ESC/ERS low-risk profile achievement accurately predicts mortality in scleroderma-associated PAH
Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension
Year: 2018
Identification and analysis of clinical phenotypes in COPD patients: PALOMB Cohort
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021
Preselection of patients at high risk for COPD by simple screening questions
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008
Clinical profile and outcomes of patients with moderate and high risk community acquired pneumonia with mixed pathogens
Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication
Year: 2007
Predicting risk of undiagnosed COPD: development and validation of the TargetCOPD score
Source: Eur Respir J, 49 (6) 1602191; 10.1183/13993003.02191-2016
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept